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Abstract
Except for viruses that initiate RNA synthesis with a protein primer (e.g., picornaviruses), most RNA viruses initiate RNA
synthesis with an NTP, and at least some of their viral pppRNAs remain unblocked during the infection. Consistent with this,
most viruses require RIG-I to mount an innate immune response, whereas picornaviruses require mda-5. We have examined
a SeV infection whose ability to induce interferon depends on the generation of capped dsRNA (without free 59 tri-
phosphate ends), and found that this infection as well requires RIG-I and not mda-5. We also provide evidence that RIG-I
interacts with poly-I/C in vivo, and that heteropolymeric dsRNA and poly-I/C interact directly with RIG-I in vitro, but in
different ways; i.e., poly-I/C has the unique ability to stimulate the helicase ATPase of RIG-I variants which lack the C-terminal
regulatory domain.
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Introduction
Virus infection elicits potent cellular responses that contain virus
spread before the adaptive immune system can intervene, and the
production of type I interferons (IFNa/b) is central to this process
[1,2]. The sensors involved in coupling recognition of virus
infection with the induction of IFNa/b have recently been
discovered. These sensors, or pattern recognition receptors (PRRs)
that recognize pathogen associated molecular patterns (PAMPs),
include RIG-I and mda-5, two cytoplasmic, RNA-binding DExD/
H box helicases (for recent reviews, see [3–5]. Both proteins
contain N-terminal CARD domains, followed by a DECH box
helicase. Both proteins also contain a C-terminal domain, which in
the case of RIG-I acts as an internal repressor or regulatory
domain (RD) that prevents the CARDs from interacting with their
downstream signaling adaptor, IPS-1 [6]. The binding of 59 tri-
phosphorylated RNA (pppRNA, which acts as a viral PAMP [7,8])
to the RD of RIG-I leads to its dimerization, which is thought to
stimulate the helicase ATPase and release the CARDs for
homotypic interaction with IPS-1 [9], the mitochondrial adaptor
of both RIG-I and mda-5. IPS-1 activation then leads to the
recruitment of a series of kinases which in turn leads to the
activation of IRF-3/7 and NF-kB and the expression of the early
IFN genes, such as IFNb.
When RIG-I was first described in the seminal paper of
Yoneyama et al [10], poly-I/C was proposed as its ligand based on
RIG-I over-expression. RIG-I deficient mice, however, were then
found not to be defective in their type I IFN response to poly-I/C
[11], whereas they were unable to mount an innate immune
response to most RNA viruses other than picornaviruses like
EMCV (e.g., Influenza A virus, VSV, JEV and Sendai virus (SeV)
[12]. Mda-5 deficient mice, in contrast, were found to be entirely
unable to mount a type I IFN response to poly-I/C and to EMCV
infection [12,13]. The role of these two helicases in the innate
immune response to virus infection was thus found to be
remarkably specific. Using cell lines derived from these mice,
mda-5
2/2 MEFs were found to activate IFN genes in response to
various transfected dsRNAs made from complementary pppRNAs
transcribed in vitro, whereas these MEFs did not respond to poly-I/
C. In contrast, RIG-I
2/2 MEFs activated IFN genes in response
to transfected poly-I/C, but these MEFs did not respond to
dsRNAs made from in vitro transcripts [12,13]. Subsequently,
ssRNA transcribed in vitro was also found to be a ligand for RIG-I,
and its ability to induce IFN upon transfection depended on the 59
triphosphate moiety of the ssRNA [7,8]. Thus, RIG-I was thought
to act as a PRR exclusively for pppRNA (independent of its single-
or double-strandedness), and mda-5 for poly-I/C, or more
realistically for the RNA elements of picornavirus infection that
are mimicked by poly-I/C.
RIG-I and mda-5 are thus thought to recognize different RNA
ligands (pppRNA and poly-I/C or dsRNA, respectively) that act as
PAMPs, which presumably accounts for the virus-specific response
of these helicases. This is consistent with our view of RNA virus
replication. Except for picornaviruses (and caliciviruses) that
initiate all RNA synthesis with a protein primer; the other RNA
viruses initiate all RNA synthesis with an NTP, and at least some
of the viral pppRNAs remain unblocked during the infection (e.g.,
the minus-strands of plus-strand and dsRNA viruses) [14]. Thus,
except for picornaviruses (and possibly caliciviruses), cells require
RIG-I (and not mda-5) to activate IFNb in response to other RNA
virus infections. In order to test this contention, we have designed
a SeV infection that generates dsRNA with capped 59 ends [15] to
examine whether this SeV infection requires mda-5 rather than
RIG-I to activate IFNb. Remarkably, this dsRNA-generating SeV
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This study also provides evidence that RIG-I binds dsRNA devoid
of free 59 tri-phosphate ends, and that poly-I/C is not a simple
analog of dsRNA; i.e., poly-I/C has the unique ability to stimulate
the helicase ATPase of RIG-I variants which lack the C-terminal
regulatory domain.
Materials and Methods
Cells, viruses, and antibodies
RIG-I
2/2 and mda-5
2/2 MEFs were obtained from H Kato
and S Akira, Osaka, Japan [11,12]. All cells were grown in
Dulbecco’s modified Eagle’s medium supplemented with 10%
fetal calf serum.
SeV-GFP(+), which expresses green fluorescent protein (GFP)
from a transgene between the M and F genes, and SeV-GFP(2),
which expresses antisense GFP mRNA from a similarly located
transgene, were prepared as previously described [16]. DI-H4
stocks were described previously [17].
Primary antibodies used included anti-Flag MAb (F1804;
Sigma), rabbit anti-mda-5 and mouse anti-Rig-I (J. Tschopp,
Lausanne, Switzerland). Rabbit anti-RIG-I which reacts with both
the human and murine helicases was provided by S. Akira (Osaka,
Japan).
Plasmids, transient transfections, infections, inductions,
and luciferase assay
Flag-tagged RIG-I, and mda-5 were obtained from Klaus
Conzelmann (Munich) and Jurg Tshopp (Lausanne). Mda5-
DCARD was obtained from S Goodbourn (London). N-terminal
deletion mutants of RIG-I (residues 242–925) were constructed by
PCR amplification with mutagenic sense primers that introduced a
Kpn I site and a met codon in lieu of phe241. C-terminal deletion
mutants were constructed with antisense primers that introduced a
stop codon and a Kpn site in lieu of Pro 797. The PCR products
were digested with kpn and then inserted into pEF-BOS (kindly
provided by J. Tschopp). The inserts of the resulting pEF-BOS
Rig-I plasmids were confirmed by sequencing.
pb-IFN-fl-lucter, which contains the firefly luciferase gene under
the control of the human IFN-b promoter, was described
previously [18]. pTK-rl-lucter, used as a transfection standard,
contains the herpes simplex virus TK promoter region upstream of
the Renilla luciferase gene (Promega).
Transfections. 100,000 cells were plated into six-well plates
20 h before transfection with 1.5 mgo fp b-IFN-fl-lucter; 0.5 mgo f
pTK-rl-lucter; 1 mg of plasmids expressing RIG-I and MDA-5;
1.5 mg of plasmids expressing RIG-DCARD, Mda-DCARD (as
indicated); and TransIT-LT1 transfection reagent (Mirus). At 24 h
posttransfection, the cells were (or were not) infected with various
SeV stocks or transfected with 5 mg of poly(I-C) using TransIT-
LT1 transfection reagent. Twenty hours later, cells were harvested
and assayed for firefly and Renilla luciferase activity (dual-luciferase
reporter assay system; Promega). Relative expression levels were
calculated by dividing the firefly luciferase values by those of
Renilla luciferase.
Immunoblotting. Cytoplasmic extracts were prepared using
0.5% NP-40 buffer. Equal amounts of total proteins were
separated by SDS-PAGE and transferred onto Immobilon-P
membranes by semi-dry transfer. The secondary antibodies used
were alkaline phosphatase-conjugated goat anti-rabbit (or mouse)
immunoglobulin G (Bio-Rad). The immobilized proteins were
detected by light-enhanced chemiluminescence (Pierce) and
analyzed in a Bio-Rad light detector using Quantity One software.
Recombinant RIG-I cloning and expression. The open
reading frame of human RIG-I was amplified by PCR using
primers designed to introduce a HindIII site upstream of the start
codon and a XhoI site downstream. The PCR products were
digested and then inserted between the same sites of pET28-
His10Smt3, to fuse the RIG-I proteins in-frame with an amino-
terminal His10Smt3 domain. RIG-I (1–796) was constructed with
an antisense primer that introduced a stop codon in place of
pro797 and a XhoI site. RIG-I (242–796) was constructed with
sense primer that introduced a HindIIII site upstream of
lys241and the antisense primer used above. The K270A
mutation was introduced by a PCR-based two-stage overlap
extension method. The plasmid inserts were sequenced completely
to ensure that unwanted mutations during amplification and
cloning had not occurred.
The pET28-His10Smt3-Tgs1 plasmids were transformed into E.
coli BL21. Cultures (500 ml) derived from single transformants
were grown at 37uC in LB medium containing 50 mg/ml
kanamycin until the A600 reached 0.6. The cultures were adjusted
to 0.2 mM IPTG and 2% ethanol and incubation was continued
for 20 h at 17u. Cells were harvested by centrifugation and stored
at 280uC. All subsequent procedures were performed at 4u.
Thawed bacteria were resuspended in 25 ml of buffer A (50 mM
Tris-HCl, pH 8.0, 200 mM NaCl, 10% glycerol) and one tablet of
protease inhibitor cocktail (Roche) and lysozyme (100 mg/ml) were
added. After incubation for 30 min, imidazole was added to a final
concentration of 5 mM and the lysate was sonicated to reduce
viscosity. Insoluble material was removed by centrifugation. The
soluble extracts were mixed for 30 min with 1.6 ml of Ni
2+-NTA-
agarose (Qiagen) that had been equilibrated with buffer A
containing 5 mM imidazole. The resins were recovered by
centrifugation, resuspended in buffer A containing 5 mM
imidazole, and poured into columns. The columns were washed
with 8 ml of 10 and 20 mM imidazole in buffer A and then eluted
step-wise with 2.5 ml aliquots of buffer A containing 50, 100, 250,
and 500 mM imidazole. The elution profiles were monitored by
SDS-PAGE. The 250 mM imidazole eluates containing the
recombinant RIG-I polypeptides were dialyzed against 50 mM
Tris-HCl, pH 8.0, 200 mM NaCl, 2 mM DTT, 1 mM EDTA,
10% glycerol and then stored at 280uC. The protein concentra-
tion was determined using the Bio-Rad dye binding method with
BSA as the standard.
qRT/PCR of endogenous IFNb mRNA
RNA was extracted from cell lysates with TRIzol reagent
(Invitrogen) and reverse transcribed with random hexamers
(Roche) and Reverse Transcriptase Superscript II (Invitrogen)
according to manufacturer’s instructions. The cDNA was then
amplified using a TaqManH 7500 (Applied Biosystems) thermo-
cycler. Results were analysed using the SDS 1.4 programme
(Applied Biosystems). 18S rRNA primers and probe sequences
used were as described previously [15]. Murine beta IFN primers
and probes used were as described in [19].
In vitro synthesis of RNA, purification, and
transfection. DNA for T7 RNA polymerase synthesis of
model RNA1 was prepared by PCR using the following partially
complementary primers: 59-TAATACGACTCACTATAgggAC-
ACACCACAACCAACCCACAAC-39 (forward) (start sites are in
lowercase type) and 59-GAAAGAAAGGTGTGGTGTTGG-
TGTGGTTGTTGTGGGTTGGTTGTGG-39 (reverse). Transcri-
ption was performed on 100 pmol of purified PCR product using
T7 MEGAshortcript from Ambion, according to the
manufacturer’s instructions. Biotinylated RNA1 was synthesized
using equal amounts of 59 biotin-UTP and UTP. The T7
IFNb Activation
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(to remove unincorporated nucleotides).
For RNA transfection, RNA was transfected into MEFss using
TransMessenger transfection reagent (QIAGEN).
The various homo-polymers were from Sigma. 59 OH
chemically synthesized Tr41 (the first 41 nt of the SeV trailer
RNA) and its complement, as well Tr41 with a 39 C12 extension
(539mer) were purchased from MicroSynth. TransIT-LT1 trans-
fection reagent was from Mirus.
pppssRNA beads
Streptavidin agarose beads (Fluka 85881) were pre-equilibrated
with Blocking buffer, i.e., Base buffer (20 mM Hepes pH 7.9,
2 mM EDTA, 15% glycerol, 0.05% NP40, 50 mM NaCl, 500
unit/ml RNasin (Promega N2515), 0.02 mg/ml tRNA (Roche
10109495001), 1% protease inhibitor cocktail (Sigma P8340) and
2 mM DTT) plus 100 mM NaCl, another 100 unit/ml RNasin,
0.1 mg/ml glycogen and 2.5 mg/ml BSA, for 2 hours at 4uC.
Biotinylated RNA was bound to the beads in Base buffer for
2 hours at 4uC. Beads to which 1.5 ug of RNA were added were
used for each assay.
Results
SeV Infections of RIG-I
2/2 and mda-5
2/2 MEFs
Unnatural SeV infection is commonly used to induce IFN, as wt
SeV infection induces IFN very poorly [17]. This is because the wt
SeV genome expresses C and V proteins which counteract the
innate immune response in several ways, most notably by their
ability to inhibit IFN activation by transfected pppRNA and poly-
I/C [15]. The extent to which IFNb is activated during SeV
infection presumably depends both on the level of the RNA
PAMPs produced and that of the viral products that counteract
the innate immune response. For mononegaviruses whose genome
and antigenome RNAs are tightly covered with N protein during
their synthesis (and thus are unlikely to act as PAMPs), small
promoter-proximal (leader and trailer) ppp RNAs are made
independent of assembly with N [15,20,21]. These promoter-
proximal ppp RNAs are essential for the control of genome
replication. Viral dsRNA could also be generated by the annealing
of trailer pppRNA and L mRNA read-thru transcripts. During wt
SeV infection of non-immune cells, the activity of both PAMPs is
presumably neutralized by the viral C proteins [15]. Akira and
coworkers have previously used SeV-C
minus infection to induce
IFN [12]. The SeV which is more commonly used to induce IFN
(‘‘Cantell strain’’) is in fact a mixed virus stock composed mostly of
copyback defective-interfering (DI) genomes, and this DI infection
both under-produces the C and V proteins and overproduces
trailer pppRNA. In addition, because some of the copyback DI
genomes are exceedingly small (546 nt vs 15,264 for wt), some of
these genomes may also be made without being assembled with N
[17]. If so, these unassembled DI genomes would self-anneal to
form pppdsRNA panhandle structures because their ends are self-
complementary [22]. Thus, both pppssRNA and pppdsRNA (i.e., in
which one strand contains a 59 tri-phosphate end) are thought to
induce IFNb activation during SeV-C
minus and DI infections.
More recently, we have also used quasi-wt SeV co-infections
that express GFP mRNA and anti-GFP mRNA (from separate
genomes) to activate IFNb [15]. The ability of this co-infection to
induce IFN depended on the presence of both complementary
GFP mRNAs in the cytoplasm, and RFP mRNA expression could
not substitute for one of the GFP mRNAs. IFNb activation
induced by the GFP+/2 co-infection thus presumably results from
the generation of GFP dsRNA in which both 59 ends are capped.
Moreover, this IFNb activation also appeared to depend on RIG-
I, as a dominant-negative form of RIG-I (RIG-I-DCARD)
inhibited this response. However, the precise manner in which
RIG-I-DCARD acts as a dominant-negative inhibitor of RIG-I is
not known, and this mutant helicase may be acting non-specifically
when over-expressed.
To further investigate the helicase requirement for the GFP+/2
infection, RIG-I
2/2 and mda-5
2/2 MEFs were transfected with
plasmids expressing luciferase under the control of the IFNb
promoter (and control plasmids), and then infected with SeV DI-
H4 or GFP+/2 stocks. Cells extracts were prepared at 20 hpi and
their luciferase activities were determined. As shown in fig 1A,
neither infection of RIG-I
2/2 MEFs activated the IFNb promoter
above background levels. When RIG-I was re-expressed in these
cells by transfection (along with the reporter plasmids), this
restored the ability of both infections to activate IFNb. In contrast,
the DI-H4 and GFP+/2 infections of mda-5
2/2 MEFs activated
Figure 1. SeV infection of RIG-I
2/2 and mda-5
2/2 MEFs. RIG-I
2/2
(panel A) and mda-5
2/2 MEFs (panel C) were transfected with pIFNb-
(ff)luciferase and pTK-(ren)luciferase, plus and minus pEBS-Flag-RIG-I
and pEBS-Flag-mda-5, respectively. Parallel cultures were then mock-
infected, or infected with either 20 pfu/cell of SeV-GFP+ and SeV-GFP2
(GFP+/2), or an equivalent amount of SeV-DI-H4 (H4) in duplicate at
24 h post-transfection. Cell extracts were prepared at 20 h.p.i. and their
luciferase activities were determined. This experiment was repeated
twice with similar results. Wild-type MEFs were also transfected with
pEBS-Flag-RIG-I and pGFP. At 24 hpt, some of the cells were analyzed
by FACS to determine the fraction expressing GFP. Cell extracts were
prepared at this time and Western blotted with antisera that recognize
both the human and murine forms of RIG-I (panel B).
doi:10.1371/journal.pone.0003965.g001
IFNb Activation
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these cells roughly doubled their response to the GFP+/2
infection, but did not stimulate their response to the DI-H4
infection (fig 1C). Thus, the presence of RIG-I is essential for IFNb
activation during GFP+/2 infection that generate capped-
dsRNA, as well as during DI-H4 infections. In contrast, the
presence of mda-5 is not essential, but can stimulate IFNb
activation in response to capped dsRNA in mda-52/2 cells.
To determine the levels of RIG-I generated by transfection
relative to those of the endogenous helicase in MEFs, wt MEFs
were also transfected with (human) p-Flag-RIG-I (and pGFP as a
transfection indicator) under identical conditions as in panels A
and C. Cell extracts were then Western blotted with an antibody
that reacts with both human and murine RIG-I. This estimation of
RIG-I levels is also more informative in wt MEFs because they are
efficiently transfected (ca 50%), in contrast to the helicase-deficient
MEFs that are poorly transfected (,5%). As shown in panel B, the
level of flag-RIG-I expressed by transfection (the upper band of
the doublet) is estimated to be 50–100% as strong as the
endogenous band. Given that 48% of these wt MEFs were
transfected (as indicated by GFP expression), Flag-RIG-I is
expressed under these condition at levels that are 1 to 2 times
those of the endogenous helicase (assuming that our anti-RIG-I
reacts equally with both forms of the helicase).
Interaction of RIG-I with poly-I/C in vivo
We would of course liketo confirm that RIG-I also senses dsRNA
without 59 tri-phosphate ends, by examining whether capped GFP
dsRNA (from SeV infected cells) activates IFNb upon transfection.
SeV infected cells, however, will also contain viral leader and trailer
Figure 2. The effect of CARD-less forms of RIG-I and mda-5 on pppRNA and poly-I/C induced IFNb activation. Parallel cultures of wt MEFs
were transfected with pIFNb-(ff)luciferase and pTK-(ren)luciferase, plus and minus either pEBS-RIG-I-DCARD (residues 242–925) or pEBS-mda-5-DCARD
(residues 197–1025). 24 h later, these cells were transfected in duplicate with either 3 ug ppp(ss)RNA1 (panel A) or 5 ug of poly-I/C (panel B). Cell
extracts were prepared after a further 20 h, and their luciferase activities were determined. Equal amounts of cell extracts (total protein) were Western
blotted with anti-flag and anti-mda-5. Cross-reacting host bands (h) serve as an internal loading control.
doi:10.1371/journal.pone.0003965.g002
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read-through transcripts), and determining the level of purity of the
GFP dsRNA is problematic. We have also tried to prepare such
capped dsRNA by capping GFP transcripts (made in vitro) with the
vaccinia virus guanylyl transferase, but we were unable to cap more
than 70% of each strand. Natural dsRNA that can be obtained in
pure form, like reovirus RNA, contains a free 59 tri-phosphate
(minus-strand) end. We therefore turned to poly-I/C that contains
59 di-phosphate ends, as model RNAs containing these 59 ends were
found not to activate RIG-I [8].
We examined the possible interaction of poly-I/C and RIG-I in
MEFs using helicases that lack their N-terminal CARDs, which
appear to act as dominant-negative inhibitors of the helicases. For
example, over-expression of the tandem CARDs of RIG-I alone
induce IFN independently of the presence of viral RNA,
suggesting that the CARDs mediate IPS-1 activation and
downstream signaling [10]. Mutation of the RIG-I ATP binding
site abolishes RIG-I activity, suggesting that ATP and RNA-
dependent conformational changes are essential for sensing viral
RNA [10]. Finally, over-expression of the RIG-I RD alone inhibits
RIG-I signaling in response to SeV DI infection, by apparently
interfering with the oligomerization of wt RIG-I [6]. RIG-I-
DCARD could then act as a dominant-negative inhibitor of RIG-I
because of its ability to bind viral RNAs and oligomerize with wt
RIG-I, but this mixed oligomer would not activate IPS-1. Less is
known about the manner in which mda-5 signals to IFNb.
When IFNb activation in MEFs in response to transfected
pppssRNA or poly-I/C is compared, this activation is largely
inhibited by the co-expression of RIG-I-DCARD in both cases
(fig 2). In contrast, the co-expression of mda-5-DCARD has no
effect on the activation induced by pppssRNA, and a mimimal
effect on that induced by poly-I/C. This does not appear to be
because mda-5-DCARD is inactive, or because RIG-I-DCARD is
acting non-specifically. When the CARD-less helicases are
expressed in RIG-I
2/2 MEFs in which mda-5 is (or is not)
expressed by transfection, mda-5-DCARD clearly inhibits the
poly-I/C induced activation due to the (over-)expressed mda-5,
whereas RIG-I-DCARD does not at all inhibit this activation that
is exclusively due to the presence of mda-5 (fig 3A). In contrast,
when the CARD-less helicases are expressed in RIG-I
2/2 MEFs
Figure 3. Effect of CARD-less helicases on poly-I/C induced IFNb activation. Parallel cultures of RIG-I
2/2 MEFs were transfected with pIFNb-
(ff)luciferase and pTK-(ren)luciferase. Some of the cultures were (or were not) transfected with plasmids expressing mda-5 (panel A; +mda-5 and ctrl)
or RIG-I (panel B; +RIG-I and ctrl), along with plasmids expressing RIG-I-DCARD or mda-5-DCARD as indicated at the bottom of each panel. 24 h later,
the cultures were transfected in duplicate with 5 ug of poly-I/C, as imdicated. Cell extracts were prepared after a further 20 h, and their luciferase
activities were determined.
doi:10.1371/journal.pone.0003965.g003
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not inhibit (but rather stimulates) the poly-I/C induced activation
due to the (over-)expressed RIG-I, whereas RIG-I-DCARD clearly
inhibits this activation in the presence of both helicases (fig 3B).
Thus, mda-5-DCARD does indeed act as an inhibitor of poly-I/C
induced IFNb activation, but only when this activation is due
exclusively to mda-5. When both helicases are present, it is RIG-I-
DCARD (and not mda-5-DCARD) that inhibits poly-I/C induced
IFNb activation.
Although the helicase-deficient MEFs transfect poorly with
plasmid DNA, they appear to be more efficiently transfected with
either relatively small poly-I/C (400 bp on average) or pppRNA
(55 nt)(fig 4). When RIG-I
2/2 MEFs are transfected with poly-I/
Co rpppRNA, the level of endogenous IFNb mRNA increases only
in response to poly-I/C as expected (fig 4A), as mda-5 does not
respond to pppRNA [12]. The increased IFNb mRNA apparently
leads to the secretion of IFN, as pretreatment of wt MEFs with the
supernatants from the above experiment efficiently prevented the
growth of VSV-GFP in these cells only when poly-I/C had been
transfected (fig 4C). In contrast, when mda-5
2/2 MEFs are
transfected with poly-I/C or pppRNA, the level of endogenous
IFNb mRNA increases in response to poly-I/C as well as to
pppRNA (fig 4B), and the supernatants from both these
transfections have the capacity to inhibit VSV-GFP replication
when used to pretreat other MEFs (fig 4D). These results further
indicate that RIG-I responds to poly-I/C as well as to pppRNA.
We also examined whether the level of IFNb activation was
proportional to that of RIG-I expression in RIG-I
2/2 MEFs.
Increasing amounts of RIG-I were expressed in these cells, which
were then subsequently transfected with either pppssRNA or poly-
I/C. Expression of increasing amounts of RIG-I had little or no
effect on IFNb activation in the absence of transfected RNA (none,
fig 5). In the presence of transfected RNA, the level of IFNb
activation was indeed proportional to that of RIG-I expression for
both poly-I/C and pppssRNA, and poly-I/C was, remarkably, half
as efficient as pppssRNA. Although it is possible that the combined
effect of poly-I/C and increasing RIG-I levels act indirectly to
increase IFNb activation (e.g., by increasing mda-5 levels), the fact
that this increase in IFNb activation depends on the presence of
both poly-I/C and increased RIG-I suggests that RIG-I can
interacts with poly-I/C in vivo.
Interaction of poly-I/C and RIG-I in vitro
DExH/D box helicases share 7 conserved sequence motifs that
mediate ATP and nucleic acid binding [23]. Nucleic acid binding
stimulates the helicase ATPase and results in a conformational
power stroke [24]. ATP binding is essential for RIG-I signaling,
but the mechanistic role of the ATPase activity in RIG-I signaling
to IFNb is unclear. RIG-I is required for non-immune cells to
mount an IFN response to SeV-C
minus and DI-H4 infections,
which presumably express different levels of pppssRNA and
pppdsRNA. RIG-I is also required for non-immune cells to mount
an IFN response to capped dsRNA (i.e., without any free 59 tri-
phosphate ends). Consistent with these results, the RIG-I ATPase
is stimulated not only by pppssRNA, but also by several dsRNAs,
including those made by annealing chemically synthesized
complementary RNAs (dsRNA-tr41, containing two 59-OH
ends)(fig 6C), bluetongue (reo)virus dsRNA (BTV RNA; 10
segments ranging from ca. 400 to 4000 bp, which contain one
capped and one 59-ppp end) (fig 6D), and poly-I/C, poly-G/C and
Figure 4. Poly-I/C and pppRNA induced activation of endogenous IFNb in helicase-deficient MEFs. RIG-I
2/2 (panel A) and mda-5
2/2 MEFs
(panel B) were transfected with either 5 ug of poly-I/C, 3 ug of pppRNA1 (55 nt) or empty transfection mix (ctrl) as indicated. Cell extracts were
prepared at 20 hpt, and the relative levels of endogenous IFNb mRNA were determined by qRT/PCR (Methods). The cell supernatants of the
transfected cells were also harvested at this time, and used to pretreat wt MEFs for 12 h before infection with VSV-GFP. The VSV infected cells were
harvested at 12 hpi and analyzed by FACS for GFP expression (panels C and D).
doi:10.1371/journal.pone.0003965.g004
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shown). In contrast, the RIG-I ATPase is not stimulated by
chemically synthesized OHssRNA (data not shown) [9]. Cui et al
have reported that pppssRNA is much more efficient in stimulating
wt RIG-I (1–925) ATPase than OHdsRNA. This difference is less
pronounced, but clear in fig 6B and C.
Two groups have recently reported that the RD of RIG-I alone
binds pppssRNA, in a shallow, positively-charged groove [9,25].
These two studies were largely in agreement, but differed in that the
RD in one case also bound relatively short OHdsRNA (25 bp)[25],
whereas that of Cui et al did not interact with OHdsRNA (50 bp)
eventhough the ATPase of a RIG-I variant lacking the CARDs was
clearly stimulated by OHdsRNA [9]. We have used streptavidin
beads containing biotinylated pppssRNA to study RNA/RIG-I
interaction.Asshown infig7,RIG-Ibinds to pppssRNAbeads(lanes
‘‘none’’(nocompetitor)vsbald beads).Asexpected,thisbindingcan
be efficiently out-competed with an excess of unmodified pppssRNA
(559mer, top panel), but the same amount of OHssRNA (419mer, top
and middle panels), poly-I or poly-C (middle panel) had no effect.
More importantly, RIG-I binding to pppssRNA can be efficiently
out-competed with relatively short OHdsRNA (41 bp, bottom panel)
under conditions where an equal amount of OHssRNA (419mer or
539mer (bottom panel)) has no effect. Poly-I/C also competed with
the bindingof RIG-I to pppssRNA (middle panel). Thus, the binding
of short OHdsRNA or poly-I/C and pppssRNA to RIG-I appear to
be mutually exclusive, either because their binding sites on RD
overlap [25], or because OHdsRNA binds to the helicase core in an
RD-dependent manner. This latter possibility is suggested by the
finding that the ATPase of a RIG-I variant lacking RD (residues 1–
793) could not be stimulated by either pppssRNA or OHdsRNA [9].
We have repeated and extended these ATPase studies, using
RIG-I-DRD (in this case residues 1–796) and RIG-I-DCARD/
DRD (242–796), as well as full-length (wt) RIG-I (1–925). As a
negative control, we examined RIG-I containing a mutation in the
Walker A box of the helicase ATP binding site (RIG-I-K270A).
We find that the RIG-I-DRD ATPase is essentially inactive with
not only pppssRNA and OHdsRNA, but is inactive as well with
poly-G/C, poly-A/U and BTV dsRNA (closed circles, fig 6, and
data not shown). Unexpectedly, we found that the RIG-I-DRD
ATPase was nevertheless clearly stimulated by poly-I/C (albeit not
as efficiently as wt RIG-I; fig 6E). In addition, the RIG-I-
DCARD/DRD ATPase was hyper-stimulated by poly-I/C as
compared to that of wt RIG-I (fig 6E). These latter results rule out
the possibility that the RIG-I ATPase somehow requires the
presence of the RD for its activity. These results are thus more
consistent with the binding of pppssRNA and OHdsRNA to
overlapping sites on RD. It is also possible that the binding of
OHdsRNA to RD is helped more by its simultaneous interaction
Figure 5. Effect of increasing RIG-I expression on RNA-induced IFNb activation. Parallel cultures of RIG-I
2/2 MEFs were transfected with
pIFNb-(ff)luciferase and pTK-(ren)luciferase. Some of the cultures were transfected with increasing amounts of plasmids expressing RIG-I. 24 h later,
the cultures were transfected in duplicate (or not (none)) with either 3 ug ppp(ss)RNA1 or 5 ug of poly-I/C. Cell extracts were prepared after a further
20 h, and their luciferase activities were determined. Equal amounts of cell extracts (total protein) were Western blotted with anti-RIG-I. Cross-
reacting host bands (h) serve as an internal loading control. The intensities of the RIG-I bands were determined by densitometry and their relative
values (RIG-I levels) are plotted above. The insert above shows a blow-up of the IFNb activation in the absence of any RIG-I.
doi:10.1371/journal.pone.0003965.g005
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summary, the ability of poly-I/C to stimulate the ATPase of RIG-I
is clearly different from that of heteropolymeric dsRNA. It appears
that poly-I/C has the unique ability to bind to both the helicase
domain and the RD, and can stimulate the helicase ATPase
independently of the RD.
Stimulation of the RIG-I ATPase is necessary but
insufficient for IFNb activation in vivo
Given that the RIG-I-DRD ATPase is stimulated by poly-I/C,
we examined whether poly-I/C could activate IFNb in vivo via this
variant of RIG-I. When additional wt RIG-I was expressed in wt
MEFs, IFNb activation in response to a fixed amount of poly I/C
increased ca. 3-fold (fig 8). However, when additional RIG-I-DRD
or RIG-I-DCARD/DRD was expressed, there was little or no
effect on poly-I/C induced IFNb activation. When additional
RIG-I-DCARD was expressed, this variant acted as a dominant-
negative inhibiter of poly-I/C induced IFNb activation, as
expected. Similar results were obtained when pppssRNA, rather
than poly-I/C was used to induce IFNb activation (data not
shown). Thus, stimulation of the ATPase is necessary but not
sufficient for poly-I/C induced IFNb activation. These results are
consistent with the finding that the RD is required for RIG-I self-
association, and that this self-association is required for down-
stream signaling [6,9]. The finding that poly-I/C also competed
with the binding of RIG-I to pppRNA (which clearly binds to the
RD)(fig 7) suggests that poly-I/C binds to both the helicase core
and the RD. These latter results are consistent with the
demonstration that the binding of pppRNA or short dsRNA to
RIG-I protects a 17kD fragment from trypsin digestion (essentially
the entire RD), whereas the binding of poly-I/C produces a 66 kD
fragment of the helicase core and the RD [25].
Figure 6. ATPase activity of RIG-I variants. (A) Samples (5 mg) of the dialyzed nickel-agarose fractions of wt Rig-I (1–925), Rig-I-DRD (1–796), Rig-
I-DCARD/DRD (242–796), and Rig-I-K270A were electrophoresed on a 10% SDS gel and visualized by Coomassie blue staining. The positions of marker
proteins are indicated on the left. (B to E) Effect of various RNAs on ATPase activity. Reaction mixtures (15 ml) containing 50 mM Tris–acetate
pH 6.0, 5 mM DTT, 1.5 mM MgCl2, 500 mM[ c-
32P]ATP, increasing amounts of either ppp-ssRNA (panel B), dsRNA-tr41 (panel C), BTV dsRNA (panel D),
or poly-I/C (panel E) as indicated, and 200 ng of recombinant proteins were incubated for 15 min at 37u. The reactions were quenched by adding
3.8 ml of 5 M formic acid. Aliquots (3 ml) of the mixtures were applied to a polyethyleneimine–cellulose thin-layer chromatography (TLC) plates and
developed with 1 M formic acid and 0.5 M LiCl.
32PO4 release was quantified with a phosphorimager. The results are plotted as a function of RNA
concentration.
doi:10.1371/journal.pone.0003965.g006
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The dsRNAs generated during nondefective SeV infection (due
to convergent transcription) or to copyback DI infection (due to
intramolecular annealing of the DI genome’s complementary
ends) would both contain one 59 tri-phosphate end. As RIG-I is
thought to be activated by pppRNA independent of its single- or
double-strandedness [7,8], the finding that IFNb activation during
SeV C
minus and DI-H4 infections require RIG-I was not
unexpected. dsRNA devoid of free 59 tri-phosphate ends, however,
is normally found only during (e.g., picornavirus) infections that
initiate RNA synthesis with protein primers, and these infections
activate IFNb via mda-5 rather than RIG-I. The finding that SeV-
GFP+/2 infections also requires RIG-I (and not mda-5; figs 1 and
2) was thus not expected. This latter finding, however, is consistent
with the recent report that pppssRNA and short OHdsRNA bind to
overlapping sites of the RIG-I RD, and that short dsRNAs will
activate IFNb via RIG-I upon transfection if they contain 59
mono-phosphates that apparently stabilize the dsRNAs intracel-
lularly [25]. We have confirmed that short OHdsRNA competes
with pppssRNA for its binding to RIG-I, whereas OHssRNA is
inactive (fig 7).
Even though it has been reported that RIG-I by itself does not
respond to poly-I/C in mda-5
2/2 MEFs [12,13], especially when
poly-I/C of 4–8 kbp in length is used [26], this does not exclude
the possibility that RIG-I participates in the cellular response to
poly-I/C when both helicases are present, or that RIG-I can
directly respond to poly-I/C when RIG-I levels are elevated.
When RIG-I levels are gradually increased in MEFs, the level of
IFNb activation is proportional to that of RIG-I expression in
response to either poly-I/C or pppssRNA (fig 5). There is other
indirect evidence that RIG-I participates in the poly-I/C induced
IFNb activation when both helicases are present. For example,
whereas Huh 7 cells respond well to poly-I/C, a sub-line of these
cells containing an incapacitating mutation in a CARD of RIG-I
(Huh 7.5 cells) has lost most of its response to this dsRNA [27]. In
addition, even though the ability of paramyxovirus V proteins
(including that of SeV) to bind mda-5 and prevent poly-I/C
induced signaling is well documented [28,29], it is the SeV C
protein (that inhibits RIG-I signaling) and not the SeV V protein
which acts to inhibit the cellular response to poly-I/C in a SeV
infection [15].
We found that both short dsRNAs containing two 59 OH ends
(dsRNA-tr41) and BTV (reovirus) dsRNAs stimulate the RIG-I
ATPase in vitro almost as efficiently as pppssRNA (fig 6).
Unexpectedly, we also found that poly-I/C stimulated the ATPase
of RIG-I variants lacking the C-terminal RD, in strong contrast to
either pppssRNA or heteropolymeric dsRNA (fig 6). Poly-I/C is an
unusual dsRNA, composed of complementary homopolymers, and
one strand being composed of the rare base inosine. Poly-I/C has
been the transfected dsRNA of choice to study IFN induction for
many years, not only because it is commercially available, but
because it works so well. It has been known for decades that poly-
I/C has a special ability to induce IFN [30]. Using DEAE-dextran
to transfect various dsRNAs into chick embryo fibroblasts, the
efficiency of IFN induction of poly-I/C was found to be orders of
magnitude greater than that of poly-G/C or poly-A/U. Moreover,
these differences in activity among the various polynucleotides did
not appear to reflect differences in their thermal stability,
sensitivity to RNase A, the rate or amount of uptake into the
cells or in the rate of intracellular breakdown. Colby and
Chamberlin (1969) presciently concluded that the high degree of
specificity of the induction process was consistent with the
existence of a specific intracellular receptor, most probably a
protein. One of the possible reasons for the remarkable ability of
poly-I/C to induce IFN may be because, unlike other dsRNAs or
pppssRNAs, it can directly bind to both the RIG-I helicase domain
as well as to mda-5, stimulating their ATPases and inducing the
conformational changes that liberate the CARDs for interaction
with IPS-1. At present, there is no clear understanding of the RNA
elements of poly-I/C that mimic the PAMPs generated during
mouse picornavirus infections, or why poly-I/C alone among
various dsRNAs stimulates the RIG-I-DRD ATPase. However, it
is becoming increasingly clear that poly-I/C is not a simple analog
of dsRNA.
While this work was being prepared for publication, Kato et al
[26] reported that the length of dsRNA is important for differential
recognition by RIG-I and mda.5. Long poly-I/C (4–8 kbp) was
found to be a specific ligand for mda-5, whereas relatively short
poly-I/C (300 bp) was a specific ligand for RIG-I. We have
examined the length of our poly-I/C by agarose gel electropho-
resis and found that it was relatively short (200–600 bp relative to
DNA markers), and the maximum length of our GFP dsRNA
would be 714 bp. Our results are thus consistent with those of
Kato et al.
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